Author:
Horton Arthur MacNeill,Soper Henry V.,McHale Teri J.
Reference81 articles.
1. Acord, L. D., & Barker, D. D. (1973). Hallucinogenic drugs and cerebral deficit. Journal of Nervous and Mental Diseases, 156, 281–283.
2. Allen, D. N., & Landis, R. K. B. (1998). Neuropsychological correlates of substance abuse disorders. In P. J. Snyder & P. D. Nussbaum (Eds.), Clinical neuropsychology: A pocket handbook for assessment (pp. 591–612). Washington, DC: American Psychological Association.
3. American Academy of Neurology, Report of Therapeutics and Technology Assessment Subcommittee. (1996). Neurology, 47, 592–599.
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., test revision). Washington, DC: Author.
5. Anker, J. J., & Carroll, M. E. (2011). Females are more vulnerable to drug abuse in males: Evidence from preclinical studies and the role of ovarian hormones. Current Topics in Behavioral Neurosciences, 8, 73–96.